化调节人参品质的机制
Wei Zhang1, Pengcheng Yu1, Wenfei Liu1
1Department of Pharmacognosy, Heilongjiang University of Chinese Medicine, Harbin, 150040, Hei-longjiang, China.
Scientific reports
|January 10, 2025
概括
酸 (SNP) 治疗通过增加人参酸含量和改善抗氧化机制来提高帕纳克斯人参的质量. 这种治疗也显示出潜在的抗衰老作用,改善了小鼠的记忆功能和氧化应激.
科学领域:
- 植物科学 植物科学
- 生物化学 生化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 帕纳克斯人参 (人参) 是一种传统的药用草本,因其活性成分 - - 素而受到重视.
- 生态压力通过通过反应性氧物种 (ROS) 调节二次新陈代谢来影响人参的质量.
- 氧化 (NO) 捐赠者,如酸 (SNP),可以调节植物的应激反应.
研究的目的:
- 研究SNP治疗对新鲜人参根的质量的影响.
- 评估SNP对金氏化物生物合成和抗氧化酶活性的影响.
- 在小鼠模型中评估SNP治疗的人参的抗衰老功效.
主要方法:
- 在连续5天内,将5岁的人参根暴露在不同度的SNP (0.1,0.5,2 mmol/L) 中.
- 测量ROS,脂质过氧化 (MDA),抗氧化酶活动 (SOD,CAT,POD,APX,GR) 和代谢物水平 (AsA,GSH/GSSG).
- 使用HPLC分析金氏化物合成途径和金氏化物含量的关键酶活性;通过莫里斯水迷宫和小鼠氧化应激标志物评估抗衰老效应.
主要成果:
- 在人参根中,SNP治疗显著增加了ROS,MDA和抗氧化酶活性.
- 最佳SNP度 (主要根0.5mmol/L,纤维根0.1mmol/L) 显著增强了人参化物生物合成途径酶,增加了各种人参化物含量.
- 与未经治疗的人参相比,SNP治疗的人参在小鼠中表现出改善记忆功能和减少氧化应激.
结论:
- SNP治疗有效模拟生态压力,激活抗氧化防御,并促进人参中的二次代谢物生产.
- SNP显著提高了新鲜人参根的质量和人参含量.
- 用SNP处理的人参表现出增强的疗效,这表明潜在的抗衰老益处.
相关概念视频
Antihypertensive Drugs: Vasodilators
473
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
473
Nitric Oxide Signaling Pathway
4.9K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
4.9K
Antianginal Drugs: Nitrates and β-Blockers
517
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
517
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
381
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
381
Drugs Acting on Autonomic Ganglia: Stimulants
1.3K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
1.3K
Heart Failure Drugs: Inotropic Agents
515
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
515


